Gender Male
Investor Type
Mark Kavulich, Partner at Athyrium.
Overview
Partner Investments
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
 uMotif |  Athyrium Capital Management LP | Series B - uMotif | |||
 Revance Therapeutics | Athyrium Capital Management LP | Post-IPO Debt - Revance Therapeutics |
Recent News and Activity
There is no recent news or activity for this profile.
